Release Date: 12/03/13 09:24 Summary: Forthcoming release of shares from escrow Price Sensitive: No Download Document 277.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%